Two large studies published in The New England Journal of Medicine found pathogenic variants in BRCA1 or BRCA2 genes raise the carrier's risk for breast cancer by nearly eightfold or more than fivefold, respectively, and protein-truncating variants in BRCA1 was linked to a tenfold higher risk. Moderate breast cancer risk was also associated with mutations in PALB2, ARD1, RAD51C, RAD51D, ATM and CHEK2 genes, and specific genes were linked to risks for specific types of breast cancer.
Large studies estimate breast cancer risk linked to specific genes
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.